Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma

Related content

• Research Outputs

• Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study

  Research output: Contribution to journal › Article › peer-review